D.E. Shaw & Co’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $208M | Sell |
432,602
-95,630
| -18% | -$49M | 0.12% | 185 |
|
|
2025
Q4 | $297M | Sell |
528,232
-71,908
| -12% | -$40.8M | 0.16% | 115 |
|
|
2025
Q3 | $309M | Buy |
600,140
+256,577
| +75% | +$112M | 0.17% | 122 |
|
|
2025
Q2 | $108M | Buy |
343,563
+129,385
| +60% | +$38.8M | 0.08% | 309 |
|
|
2025
Q1 | $65.3M | Buy |
214,178
+35,898
| +20% | +$12.1M | 0.06% | 395 |
|
|
2024
Q4 | $59.2M | Sell |
178,280
-30,261
| -15% | -$10.3M | 0.04% | 499 |
|
|
2024
Q3 | $69.6M | Sell |
208,541
-91,324
| -30% | -$34.7M | 0.06% | 386 |
|
|
2024
Q2 | $123M | Sell |
299,865
-72,214
| -19% | -$28.6M | 0.12% | 196 |
|
|
2024
Q1 | $150M | Buy |
372,079
+140,519
| +61% | +$49.4M | 0.13% | 160 |
|
|
2023
Q4 | $71M | Buy |
231,560
+87,240
| +60% | +$23.5M | 0.06% | 363 |
|
|
2023
Q3 | $34.9M | Sell |
144,320
-114,693
| -44% | -$29.3M | 0.04% | 570 |
|
|
2023
Q2 | $62.2M | Buy |
259,013
+108,623
| +72% | +$22.6M | 0.06% | 362 |
|
|
2023
Q1 | $28.3M | Buy |
150,390
+7,861
| +6% | +$1.63M | 0.03% | 695 |
|
|
2022
Q4 | $30.3M | Buy |
142,529
+98,200
| +222% | +$19.6M | 0.03% | 668 |
|
|
2022
Q3 | $6.97M | Sell |
44,329
-1,714
| -4% | -$274K | 0.01% | 1722 |
|
|
2022
Q2 | $6.89M | Buy |
46,043
+22,272
| +94% | +$3.22M | 0.01% | 1765 |
|
|
2022
Q1 | $3.89M | Buy |
23,771
+12,346
| +108% | +$2.04M | ﹤0.01% | 2609 |
|
|
2021
Q4 | $2.49M | Buy |
11,425
+3,698
| +48% | +$774K | ﹤0.01% | 3154 |
|
|
2021
Q3 | $1.46M | Sell |
7,727
-9,462
| -55% | -$1.73M | ﹤0.01% | 3296 |
|
|
2021
Q2 | $3.04M | Sell |
17,189
-17,112
| -50% | -$2.95M | ﹤0.01% | 2512 |
|
|
2021
Q1 | $5.63M | Sell |
34,301
-50,253
| -59% | -$7.69M | 0.01% | 1759 |
|
|
2020
Q4 | $11.8M | Sell |
84,554
-184,076
| -69% | -$23.2M | 0.01% | 1288 |
|
|
2020
Q3 | $30M | Buy |
268,630
+41,310
| +18% | +$4.78M | 0.03% | 630 |
|
|
2020
Q2 | $21.1M | Sell |
227,320
-50,452
| -18% | -$4.29M | 0.03% | 750 |
|
|
2020
Q1 | $20.4M | Buy |
277,772
+91,079
| +49% | +$7.91M | 0.03% | 609 |
|
|
2019
Q4 | $15.7M | Sell |
186,693
-104,933
| -36% | -$8.12M | 0.02% | 945 |
|
|
2019
Q3 | $24.5M | Buy |
291,626
+120,688
| +71% | +$9.12M | 0.03% | 685 |
|
|
2019
Q2 | $11.2M | Sell |
170,938
-43,234
| -20% | -$2.49M | 0.01% | 1073 |
|
|
2019
Q1 | $12.6M | Sell |
214,172
-85,293
| -28% | -$5.09M | 0.02% | 961 |
|
|
2018
Q4 | $15.9M | Sell |
299,465
-241,334
| -45% | -$13.2M | 0.02% | 809 |
|
|
2018
Q3 | $32.4M | Buy |
540,799
+436,834
| +420% | +$23.9M | 0.04% | 556 |
|
|
2018
Q2 | $4.47M | Sell |
103,965
-7,209
| -6% | -$291K | 0.01% | 1625 |
|
|
2018
Q1 | $3.88M | Sell |
111,174
-55,859
| -33% | -$2.04M | 0.01% | 1574 |
|
|
2017
Q4 | $6.06M | Buy |
167,033
+101,341
| +154% | +$3.55M | 0.01% | 1362 |
|
|
2017
Q3 | $2.1M | Sell |
65,692
-8,266
| -11% | -$252K | ﹤0.01% | 1985 |
|
|
2017
Q2 | $2.15M | Buy |
+73,958
| New | +$2.07M | ﹤0.01% | 1930 |
|
Other funds holding MEDP
VPM
VCM
WA
D.E. Shaw & Co's MEDP Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Medpace (MEDP) stake by 18% in Q1 2026, selling an estimated $49M and leaving 432,602 shares worth $208M. The position accounts for 0.12% of the portfolio, ranked #185.
D.E. Shaw & Co first reported a position in MEDP in Q2 2017 and has held it in 36 quarters since. The position peaked at $309M in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- D.E. Shaw & Co held 432,602 shares of Medpace worth $208M as of Q1 2026.
- D.E. Shaw & Co sold 95,630 Medpace shares in Q1 2026, an estimated $49M.
- Medpace made up 0.12% of D.E. Shaw & Co's portfolio in Q1 2026, its #185 holding.
- D.E. Shaw & Co first reported a position in Medpace in Q2 2017 and has held it in 36 quarters since.
- D.E. Shaw & Co's Medpace position peaked at $309M in Q3 2025.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.